SCHEMBL1610107

SCHEMBL1610107

CCC(C)(C)N(C#N)C(=N)Nc1cccnc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
ABCC9 O60706 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
KMT2A Q03164 1/20 0.51
ABCC8 Q09428 1/20 0.51
KCNJ11 Q14654 1/20 0.51
KCNJ8 Q15842 1/20 0.51
LMNA P02545 2/20 0.46
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
TRPV1 Q8NER1 3/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
POLB P06746 1/20 0.42
TSHR P16473 1/20 0.42
NAMPT P43490 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PKM P14618 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984084 0.76 LMNA (0.49) MEN1ABCC9CYP1A2CYP3A4CYP2D6
SCHEMBL7983304 0.74 LMNA (0.47) MEN1ABCC9CYP1A2CYP3A4CYP2D6
SCHEMBL9844456 0.74 L3MBTL1 (0.35) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL7977100 0.73 LMNA (0.44) MEN1ABCC9CYP1A2CYP3A4CYP2D6
SCHEMBL7980734 0.73 LMNA (0.46) MEN1ABCC9CYP1A2CYP3A4CYP2D6
SCHEMBL7980436 0.73 LMNA (0.46) MEN1ABCC9CYP1A2CYP3A4CYP2D6
SCHEMBL7983319 0.73 LMNA (0.46) MEN1ABCC9CYP1A2CYP3A4CYP2D6
SCHEMBL7977410 0.73 LMNA (0.46) MEN1ABCC9CYP1A2CYP3A4CYP2D6
SCHEMBL7978761 0.73 LMNA (0.46) MEN1ABCC9CYP1A2CYP3A4CYP2D6
SCHEMBL3701757 0.72 ABCC9 (0.63) MEN1ABCC9CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020077256-A1 NOVEL DETERGENT COMPOSITIONS WITH ENHANCED DEPOSITING, CONDITIONING AND SOFTNESS CAPABILITIES JOHNSON & JOHNSON CONSUMER INC. 2002-06-20 US claimed
EP-3091968-B1 PROCESS FOR FORMING A MULTILAYERED SHAPED FILM KENVUE BRANDS LLC (US) 2025-10-29 EP disclosed
US-20250248911-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen COLABS INT'L CORP. (US) 2025-08-07 US disclosed
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents COLABS INT'L CORP. (US) 2024-03-28 US disclosed
EP-3091969-B1 PROCESS FOR FORMING A SHAPED FILM PRODUCT JOHNSON & JOHNSON CONSUMER INC (US) 2024-01-24 EP disclosed
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents CoLabs International Corporation (US) 2023-12-12 US disclosed
US-20230338252-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen COLABS INT'L CORP. (US) 2023-10-26 US disclosed
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CoLabs International Corporation (US) 2023-08-15 US disclosed
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent COLABS INT'L CORP. (US) 2023-07-25 US disclosed
US-11690793-B2 Composition containing a cellulose derived capsule with a sunscreen COLABS INT'L CORP. (US) 2023-07-04 US disclosed
US-20020102295-A1 Compositions for application to the skin or hair JOHNSON & JOHNSON CONSUMER COMPANIES, INC. 2002-08-01 US disclosed
EP-1216685-A2 Personal care compositions Johnson & Johnson Consumer Companies, Inc. (US) 2002-06-26 EP disclosed
US-20020077256-A1 NOVEL DETERGENT COMPOSITIONS WITH ENHANCED DEPOSITING, CONDITIONING AND SOFTNESS CAPABILITIES JOHNSON & JOHNSON CONSUMER INC. 2002-06-20 US disclosed
US-20020035046-A1 Personal care compositions JOHNSON & JOHNSON CONSUMER INC. 2002-03-21 US disclosed
US-20020001613-A1 Method of manufacturing liposomes JOHNSON & JOHNSON CONSUMER COMPANIES, INC. 2002-01-03 US disclosed
WO-2001001949-A9 CLEANSING COMPOSITIONS JOHNSON & JOHNSON CONSUMER (US) 2001-03-22 WO disclosed
EP-1080714-A2 Detergent compositions with enhanced depositing, conditioning and softness capabilities Johnson & Johnson Consumer Companies, Inc. (US) 2001-03-07 EP disclosed
WO-2001001949-A1 CLEANSING COMPOSITIONS JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) 2001-01-11 WO disclosed
EP-1060732-A2 Novel topical formulations comprising vesicle delivery systems JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) 2000-12-20 EP disclosed
US-5244664-A Hair growth LEO PHARMACEUTICAL PRODUCTS LTD. (DK) 1993-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent CUTA, LIPE, LIPA MEN1 299/4885ABCC9 4167/4885CYP1A2 2522/4885
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CUTA, ACMSD, TYR MEN1 139/4885ABCC9 2779/4885CYP1A2 1054/4885
US-20230338252-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen MSH6, TYR, CUTA MEN1 59/4885ABCC9 2848/4885CYP1A2 400/4885
US-20020035046-A1 Personal care compositions CUTA, DSG1, KRT18 MEN1 2871/4885ABCC9 717/4885CYP1A2 4130/4885
US-20020102295-A1 Compositions for application to the skin or hair PLIN5, PLIN3, ATP6V0C MEN1 3547/4885ABCC9 582/4885CYP1A2 3587/4885
US-20020077256-A1 NOVEL DETERGENT COMPOSITIONS WITH ENHANCED DEPOSITING, CONDITIONING AND SOFTNESS CAPABILITIES DSTN, CTTN, SMURF1 MEN1 1258/4885ABCC9 796/4885CYP1A2 4581/4885
US-20020001613-A1 Method of manufacturing liposomes LIPA, CLPTM1L, SGMS1 MEN1 1709/4885ABCC9 1160/4885CYP1A2 4236/4885
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents MSN, LIPE, CUTA MEN1 84/4885ABCC9 4812/4885CYP1A2 2852/4885
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents MSN, LIPE, CUTA MEN1 81/4885ABCC9 4815/4885CYP1A2 2906/4885
US-11690793-B2 Composition containing a cellulose derived capsule with a sunscreen MSH6, TYR, CUTA MEN1 59/4885ABCC9 2848/4885CYP1A2 400/4885
US-20250248911-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen MSH6, TYR, CUTA MEN1 59/4885ABCC9 2848/4885CYP1A2 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.